Functionally, aberrant NF-κB activation demonstrated in the majority of colorectal and colitis-associated tumors, can follow two different routes: the canonical (synonymous: classical) route or the noncanonical (synonymous: alternative) activation pathway [137,138]. Here, NFKB1 is linked to colitis.